Latest Trends in Design of Pivotal Phase Iii Clinical Trials for Peripheral T-Cell Lymphoma

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.03.1674
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Hematopoietic SCT for Peripheral T-Cell Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2008English

Angioimmunoblastic T-Cell Lymphoma: A Rare Subtype of Peripheral T-Cell Lymphoma

Clinical Case Reports
Medicine
2018English

Therapeutic Options in Peripheral T Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Prognostic Markers in Peripheral T-Cell Lymphoma

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2010English

Phase I to III Trials of Anti-B Cell Therapy in Non-Hodgkin's Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2007English

Laboratory Correlates for a Phase II Trial of Romidepsin in Cutaneous and Peripheral T-Cell Lymphoma

British Journal of Haematology
Hematology
2010English

Peripheral T-Cell Lymphoma Mimicking Marginal Zone B-Cell Lymphoma

Modern Pathology
Forensic MedicinePathology
2002English

Chidamide in the Treatment of Peripheral T-Cell Lymphoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Design and Inference in Phase II/III Clinical Trials Incorporating Monitoring of Multiple Endpoints.

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy